Colostrinin decreases spontaneous and induced mutation frequencies at the hprt locus in Chinese hamster V79 cells

Attila Bacsi, Leopolde Aguilera-Aguirre, Peter German, Marian L. Kruzel, Istvan Boldogh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Colostrinin™ (CLN), a uniform mixture of low-molecular weight, proline-rich polypeptides, induces neurite outgrowth of pheochromocytoma cells, extends the lifespan of diploid fibroblast cells, inhibits beta amyloid-induced apoptosis and resulted in improved cognitive function when administered to Alzheimer's patients. Here we investigated CLN's antimutagenic activity in cells stressed oxidatively or exposed to chemical or physical agents. Our data show that CLN did not alter cell cycle kinetics and cloning efficiency, while it inhibited the development of spontaneous mutations at the coding region of the hypoxanthine phosphoribosyl-transferase (hprt) gene in Chinese hamster V79 cells. In a dose-dependent manner, CLN lowered reactive oxygen species (ROS)-induced frequency of cells resistant to 6-thioguanine (6-TG) to nearly background level. Likewise, CLN decreased the frequency of methyl methanesulfonate- or mitomycin C-induced mutations in V79 cells. Notably, CLN (at 100, 250, and 500 ng per ml concentrations) decreased UVA-induced mutation frequency, while only the highest dose of CLN also decreased significantly the number of UVB-induced 6-TG-resistant mutant cells. Similar results were obtained using cell cultures of human origin. Overall, our data show that CLN significantly lowers the mutation frequency that develops spontaneously or is induced by ROS, chemical and physical agents. CLN itself has no mutagenic activity. Therefore, CLN may be used in human therapies systemically and/or locally for the prevention of diseases associated with sequence alterations in genomic and mitochondrial DNA.

Original languageEnglish (US)
Pages (from-to)249-259
Number of pages11
JournalJournal of Experimental Therapeutics and Oncology
Volume5
Issue number4
StatePublished - 2006

Fingerprint

Hypoxanthine
Mutation Rate
Transferases
Cricetulus
Thioguanine
Reactive Oxygen Species
Methyl Methanesulfonate
colostrinine
Mutation
Mitomycin
Pheochromocytoma
Diploidy
Mitochondrial DNA
Amyloid
Proline
Cognition
Organism Cloning
Cell Cycle
Cell Culture Techniques
Fibroblasts

Keywords

  • Colostrinin™
  • Genotoxic chemical and physical agents
  • Mutation frequency
  • Oxidative stress

ASJC Scopus subject areas

  • Pharmacology
  • Cancer Research

Cite this

Colostrinin decreases spontaneous and induced mutation frequencies at the hprt locus in Chinese hamster V79 cells. / Bacsi, Attila; Aguilera-Aguirre, Leopolde; German, Peter; Kruzel, Marian L.; Boldogh, Istvan.

In: Journal of Experimental Therapeutics and Oncology, Vol. 5, No. 4, 2006, p. 249-259.

Research output: Contribution to journalArticle

Bacsi, Attila ; Aguilera-Aguirre, Leopolde ; German, Peter ; Kruzel, Marian L. ; Boldogh, Istvan. / Colostrinin decreases spontaneous and induced mutation frequencies at the hprt locus in Chinese hamster V79 cells. In: Journal of Experimental Therapeutics and Oncology. 2006 ; Vol. 5, No. 4. pp. 249-259.
@article{d515264ac38548fa9605915f35b97f49,
title = "Colostrinin decreases spontaneous and induced mutation frequencies at the hprt locus in Chinese hamster V79 cells",
abstract = "Colostrinin™ (CLN), a uniform mixture of low-molecular weight, proline-rich polypeptides, induces neurite outgrowth of pheochromocytoma cells, extends the lifespan of diploid fibroblast cells, inhibits beta amyloid-induced apoptosis and resulted in improved cognitive function when administered to Alzheimer's patients. Here we investigated CLN's antimutagenic activity in cells stressed oxidatively or exposed to chemical or physical agents. Our data show that CLN did not alter cell cycle kinetics and cloning efficiency, while it inhibited the development of spontaneous mutations at the coding region of the hypoxanthine phosphoribosyl-transferase (hprt) gene in Chinese hamster V79 cells. In a dose-dependent manner, CLN lowered reactive oxygen species (ROS)-induced frequency of cells resistant to 6-thioguanine (6-TG) to nearly background level. Likewise, CLN decreased the frequency of methyl methanesulfonate- or mitomycin C-induced mutations in V79 cells. Notably, CLN (at 100, 250, and 500 ng per ml concentrations) decreased UVA-induced mutation frequency, while only the highest dose of CLN also decreased significantly the number of UVB-induced 6-TG-resistant mutant cells. Similar results were obtained using cell cultures of human origin. Overall, our data show that CLN significantly lowers the mutation frequency that develops spontaneously or is induced by ROS, chemical and physical agents. CLN itself has no mutagenic activity. Therefore, CLN may be used in human therapies systemically and/or locally for the prevention of diseases associated with sequence alterations in genomic and mitochondrial DNA.",
keywords = "Colostrinin™, Genotoxic chemical and physical agents, Mutation frequency, Oxidative stress",
author = "Attila Bacsi and Leopolde Aguilera-Aguirre and Peter German and Kruzel, {Marian L.} and Istvan Boldogh",
year = "2006",
language = "English (US)",
volume = "5",
pages = "249--259",
journal = "Journal of Experimental Therapeutics and Oncology",
issn = "1359-4117",
publisher = "Old City Publishing",
number = "4",

}

TY - JOUR

T1 - Colostrinin decreases spontaneous and induced mutation frequencies at the hprt locus in Chinese hamster V79 cells

AU - Bacsi, Attila

AU - Aguilera-Aguirre, Leopolde

AU - German, Peter

AU - Kruzel, Marian L.

AU - Boldogh, Istvan

PY - 2006

Y1 - 2006

N2 - Colostrinin™ (CLN), a uniform mixture of low-molecular weight, proline-rich polypeptides, induces neurite outgrowth of pheochromocytoma cells, extends the lifespan of diploid fibroblast cells, inhibits beta amyloid-induced apoptosis and resulted in improved cognitive function when administered to Alzheimer's patients. Here we investigated CLN's antimutagenic activity in cells stressed oxidatively or exposed to chemical or physical agents. Our data show that CLN did not alter cell cycle kinetics and cloning efficiency, while it inhibited the development of spontaneous mutations at the coding region of the hypoxanthine phosphoribosyl-transferase (hprt) gene in Chinese hamster V79 cells. In a dose-dependent manner, CLN lowered reactive oxygen species (ROS)-induced frequency of cells resistant to 6-thioguanine (6-TG) to nearly background level. Likewise, CLN decreased the frequency of methyl methanesulfonate- or mitomycin C-induced mutations in V79 cells. Notably, CLN (at 100, 250, and 500 ng per ml concentrations) decreased UVA-induced mutation frequency, while only the highest dose of CLN also decreased significantly the number of UVB-induced 6-TG-resistant mutant cells. Similar results were obtained using cell cultures of human origin. Overall, our data show that CLN significantly lowers the mutation frequency that develops spontaneously or is induced by ROS, chemical and physical agents. CLN itself has no mutagenic activity. Therefore, CLN may be used in human therapies systemically and/or locally for the prevention of diseases associated with sequence alterations in genomic and mitochondrial DNA.

AB - Colostrinin™ (CLN), a uniform mixture of low-molecular weight, proline-rich polypeptides, induces neurite outgrowth of pheochromocytoma cells, extends the lifespan of diploid fibroblast cells, inhibits beta amyloid-induced apoptosis and resulted in improved cognitive function when administered to Alzheimer's patients. Here we investigated CLN's antimutagenic activity in cells stressed oxidatively or exposed to chemical or physical agents. Our data show that CLN did not alter cell cycle kinetics and cloning efficiency, while it inhibited the development of spontaneous mutations at the coding region of the hypoxanthine phosphoribosyl-transferase (hprt) gene in Chinese hamster V79 cells. In a dose-dependent manner, CLN lowered reactive oxygen species (ROS)-induced frequency of cells resistant to 6-thioguanine (6-TG) to nearly background level. Likewise, CLN decreased the frequency of methyl methanesulfonate- or mitomycin C-induced mutations in V79 cells. Notably, CLN (at 100, 250, and 500 ng per ml concentrations) decreased UVA-induced mutation frequency, while only the highest dose of CLN also decreased significantly the number of UVB-induced 6-TG-resistant mutant cells. Similar results were obtained using cell cultures of human origin. Overall, our data show that CLN significantly lowers the mutation frequency that develops spontaneously or is induced by ROS, chemical and physical agents. CLN itself has no mutagenic activity. Therefore, CLN may be used in human therapies systemically and/or locally for the prevention of diseases associated with sequence alterations in genomic and mitochondrial DNA.

KW - Colostrinin™

KW - Genotoxic chemical and physical agents

KW - Mutation frequency

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=33749315286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749315286&partnerID=8YFLogxK

M3 - Article

C2 - 17024966

AN - SCOPUS:33749315286

VL - 5

SP - 249

EP - 259

JO - Journal of Experimental Therapeutics and Oncology

JF - Journal of Experimental Therapeutics and Oncology

SN - 1359-4117

IS - 4

ER -